Yu Zhao, Chief Executive Officer of Adjuvax LLC, has over 15 years of experience in biomedical industry research and management. Her expertise includes mammalian cell protein expression, stable cell line generation and characterization, and molecular biology.
Weiwei Li, Chief Financial Officer of Adjuvax LLC, has 15+ years of experience in accounting in government and healthcare.
At Adjuvax, we are dedicated to developing potent, cost-effective, structurally defined, and highly accessible saponin adjuvants with diverse activity profiles tailored to various vaccine applications.
Stay Connected: